Deficiency of cyclic AMP-dependent protein kinases in human psoriasis
- PMID: 3014540
- PMCID: PMC323933
- DOI: 10.1073/pnas.83.14.5272
Deficiency of cyclic AMP-dependent protein kinases in human psoriasis
Abstract
To determine possible differences in the cyclic AMP-dependent protein kinases of normal and psoriatic human fibroblasts, the levels of the regulatory subunits (RI and RII, respectively) of protein kinase I and protein kinase II were quantitated by photoaffinity labeling with 8-azido[32P]cAMP. The level of RII was significantly decreased, or was undetectable, in cytosol prepared from fibroblasts from five psoriatic subjects when compared to RII levels found with normal human fibroblasts. The level of cytosolic RI was decreased in fibroblasts from four psoriatic patients and was within the normal range for one diseased patient when compared to RI levels in normal human fibroblasts. The elution profile from a DEAE-cellulose column of protein kinase activity in the soluble fraction from two psoriatic patients also showed a decrease in type I kinase activity and the complete absence of type II kinase activity. Other results indicate that the level of RI in erythrocyte membranes from psoriatic subjects is significantly decreased when compared to that of erythrocyte membranes from eight normal subjects. A significant correlation (P less than 0.001) was observed between the severity of the cutaneous manifestation of the disease and the level of RI in psoriatic erythrocyte membranes. The changes noted in the levels of RI and RII in cell types other than those thought to be specifically involved in the proliferative epidermis disorder of the disease suggest a general protein kinase deficiency.
Similar articles
-
Retinoylation of the type II cAMP-binding regulatory subunit of cAMP-dependent protein kinase is increased in psoriatic human fibroblasts.J Cell Physiol. 1996 May;167(2):196-203. doi: 10.1002/(SICI)1097-4652(199605)167:2<196::AID-JCP2>3.0.CO;2-K. J Cell Physiol. 1996. PMID: 8613459
-
Retinoid treatment of human psoriatic fibroblasts induces an increase in cyclic AMP-dependent protein kinase activity.J Invest Dermatol. 1987 Jul;89(1):105-10. doi: 10.1111/1523-1747.ep12580448. J Invest Dermatol. 1987. PMID: 3598199
-
Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis.Free Radic Biol Med. 1997;22(4):623-32. doi: 10.1016/s0891-5849(96)00353-x. Free Radic Biol Med. 1997. PMID: 9013125
-
Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.J Invest Dermatol. 1998 Apr;110(4):332-7. doi: 10.1046/j.1523-1747.1998.00149.x. J Invest Dermatol. 1998. PMID: 9540970
-
Rapid effect of treatment of psoriatic erythrocytes with the synthetic retinoid acitretin to increase 8-azido cyclic AMP binding to the RI regulatory subunit.J Invest Dermatol. 1993 Jan;100(1):77-81. doi: 10.1111/1523-1747.ep12354923. J Invest Dermatol. 1993. PMID: 8380830
Cited by
-
β-Adrenergic Receptor Trafficking, Degradation, and Cell Surface Expression Are Altered in Dermal Fibroblasts from Hypertrophic Scars.J Invest Dermatol. 2018 Jul;138(7):1645-1655. doi: 10.1016/j.jid.2018.01.037. Epub 2018 Feb 22. J Invest Dermatol. 2018. PMID: 29476776 Free PMC article. Clinical Trial.
-
High chemotactic response to platelet-derived growth factor of a teratocarcinoma differentiated mesodermal cell line.In Vitro Cell Dev Biol. 1990 Apr;26(4):388-92. doi: 10.1007/BF02623830. In Vitro Cell Dev Biol. 1990. PMID: 2160926
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical